Simplified criteria for the diagnosis of autoimmune hepatitis†Elke Hennes, Ansgar W. Lohse, Albert J. Czaja et al.|Hepatology|2008Cited by 1.9k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular CarcinomaGhassan K. Abou‐Alfa, Bruno Sangro, George Lau et al.|NEJM Evidence|2022Cited by 1.4k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Juan F. Gallegos‐Orozco, Velimir A. Luketic et al.|Gastroenterology|2016Cited by 1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJordi Bruix, Josep M. Llovet, Jean‐Luc Raoul et al.|Journal of Hepatology|2012Cited by 821
Biology and significance of alpha‐fetoprotein in hepatocellular carcinomaPeter R. Galle, Andrew X. Zhu, Friedrich Foerster et al.|Liver International|2019Cited by 591